TRPV1 Channel: A Potential Drug Target for Treating Epilepsy

E-ISSN： 1875-6190|13|2|239-247

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.13, Iss.2, 2015-03, pp. : 239-247

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sodium Channel Blockers as Therapeutic Target for Treating Epilepsy: Recent Updates

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 9, 2012-05 ,pp. : 962-970

Bentham Science Publishers

Access to resources Recommend Favorite

Could Hippocampal Neurogenesis be a Future Drug Target for Treating Temporal Lobe Epilepsy?

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 5, 2007-10 ,pp. : 342-357

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of Immunity and the Inflammatory Response: A New Target for Treating Drug-resistant Epilepsy

Current Neuropharmacology, Vol. 11, Iss. 1, 2013-01 ,pp. : 114-127

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Structure of Transient Receptor Potential Vanilloid Type 1 Ion Channel (TRPV1)

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 1, 2011-01 ,pp. : 115-121

Bentham Science Publishers

Access to resources Recommend Favorite

TRPV1: A Target for Next Generation Analgesics

Current Neuropharmacology, Vol. 6, Iss. 2, 2008-06 ,pp. : 151-163

Bentham Science Publishers

Access to resources Recommend Favorite